Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Prochlorperazine maleate from Chartwell RX, LLC. The product is used to treat nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROCHLORPERAZINE MALEATE (prochlorperazine maleate)

Snippet

SUPPL AP for PROCHLORPERAZINE MALEATE (PROCHLORPERAZINE MALEATE)